Patent · US Active

HLA-A2 tumor associated antigen peptides and compositions

US9913884B2 · kind B2 · utility

10Cited by
4References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 28, 2016
Grant dateMar 13, 2018
Priority date—
Expiry dateJun 28, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2239/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A peptide or composition comprising at least one HLA-A2 epitope or analog from CEA, HER2/neu, MAGE2, MAGE3, or p53.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.